vimarsana.com

Page 27 - நிறுவனம் காலாண்டு அறிக்கை ஆன் வடிவம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BIOMEA Fusion Strengthens its Executive Team with

BIOMEA Fusion Strengthens its Executive Team with Appointment of Franco Valle as Chief Financial Officer June 28, 2021 19:10 ET | Source: Biomea Fusion, Inc. Biomea Fusion, Inc. Redwood City, California, UNITED STATES REDWOOD CITY, Calif., June 28, 2021 (GLOBE NEWSWIRE) Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a preclinical-stage biopharmaceutical company focused on the discovery and development of irreversible small molecules to treat patients with genetically defined cancers, announced the appointment of Franco Valle as Chief Financial Officer. Mr. Valle is an accomplished financial expert who brings extensive experiences to Biomea, in particular with building the necessary infrastructure to support clinical and operational growth within biotech companies. Mr. Valle will also assume the role of Principal Financial Officer and Principal Accounting Officer upon joining.

BIOMEA Fusion Strengthens its Executive Team with Appointment of Franco Valle as Chief Financial Officer - Press Release

REDWOOD CITY, Calif., June 28, 2021 (GLOBE NEWSWIRE) Biomea Fusion, Inc. (“Biomea”) (NASDAQ:BMEA), a preclinical-stage biopharmaceutical company focused on the discovery and development of irreversible small molecules to treat patients with genetically defined cancers, announced the appointment of Franco Valle as Chief Financial Officer. Mr. Valle is an accomplished financial expert who brings extensive experiences to Biomea, in particular with building the necessary infrastructure to support clinical and operational growth within biotech companies. Mr. Valle will also assume the role of Principal Financial Officer and Principal Accounting Officer upon joining. Recently, Mr. Valle served as Principal Accounting Officer & Senior Vice President of Finance at Eidos (NASDAQ:EIDX), a former publicly traded, clinical-stage biopharmaceutical company, which merged with BridgeBio (NASDAQ:BBIO) for $2.83 Billion earlier in 2021. Prior to Eidos, Mr. Valle served as the Principal Accounti

Dorman Products, Inc to Acquire Dayton Parts

Dorman Products, Inc. to Acquire Dayton Parts Highlights: Dorman Products, Inc. signed a definitive agreement to acquire Dayton Parts, a leading independent heavy-duty undercarriage aftermarket component supplier for $338 million. The addition of Dayton Parts accelerates Dorman’s heavy-duty growth strategy by adding large and complementary offerings of undercarriage components in the commercial vehicle aftermarket, a vast distribution network and a trusted brand with over 100 years of experience. The acquisition is expected to be immediately accretive to adjusted diluted earnings per share, excluding one-time charges and acquisition-related intangible assets amortization. In connection with the transaction, Dorman expects to enter into a new $600 million revolving credit facility.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.